ICAM1 and type 2 diabetes mellitus: However, in terms of the major adverse cardiovascular events, VCAM-1 concentration is significantly associated with cardiovascular mortality in type 2 diabetes patients [38], and circulating levels of soluble VCAM-1, ICAM-1 are shown to be elevated in diabetic patients with stroke [39].